Journal
ONCOGENE
Volume 29, Issue 31, Pages 4378-4387Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2010.183
Keywords
HIPK2; p53; post-translational modifications; protein conformation; apoptosis; chemoresistance
Funding
- Italian Association for Cancer Research
- University 'Gd'Annunzio'
- Italian Foundation for Cancer Research (FIRC)
Ask authors/readers for more resources
The p53 protein is the most studied tumor suppressor and the p53 pathway has been shown to mediate cellular stress responses that are disrupted when cancer develops. After DNA damage, p53 is activated as transcription factor to directly induce the expression of target genes involved in cell-cycle arrest, DNA repair, senescence and, importantly, apoptosis. Post-translational modifications of p53 are essential for the activation of p53 and for selection of target genes. The tumor suppressor homeodomain-interacting protein kinase-2 (HIPK2) is a crucial regulator of p53 apoptotic function by phosphorylating its N-terminal serine 46 (Ser46) and facilitating Lys382 acetylation at the C-terminus. HIPK2 is activated by numerous genotoxic agents and can be deregulated in tumors by several conditions including hypoxia. Recent findings suggest that HIPK2 active/inactive protein can affect p53 function in multiple and unexpected ways. This makes p53 as well as HIPK2 interesting targets for cancer therapy. Hence, understanding the role of HIPK2 as p53 activator may provide important insights in the process of tumor progression, and may also serve as the crucial point in the diagnostic and therapeutical aspects of cancer. Oncogene (2010) 29, 4378-4387; doi: 10.1038/onc.2010.183; published online 31 May 2010
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available